Navigation Links
TomoTherapy reports 86% revenue jump, $131M net loss in Q1

Madison, Wis. - TomoTherapy saw its revenues surge by 86 percent and its net loss grow to $131.1 million, according to the first earnings report issued since it officially became a publicly traded company.

The company also announced that it has joined a researc......

Full article >>> ngs statement emphasized the company's pro forma net income of $3.9 million, or nine cents per diluted share, up from a pro forma net loss of $1.5 million, or four cents per diluted share, in Q1 of 2006.

TomoTherapy is increasing its operating expenses to continue to build its sales and service organizations, and invest in research and development and infrastructure. Total operating expe......

Full article >>> herapy facilities.

Lawrence Livermore has worked to develop the accelerator technology, which is the result of defense-related research, with the University of California-Davis Cancer Center. The center helped finance the early development of the technology as a proton accelerator for cancer treatment.

Six of the 25 proton therap......

Full article >>>
'"/>

Source:wistechnology.com By WTN News 06/14/07


Related biology technology :

1. TomoTherapy opens technical training center
2. TomoTherapy raises $223 million in IPO
3. TomoTherapy revises IPO money target
4. Hospital named for Madame Curie installs TomoTherapy system
5. TomoTherapy files registration statement for IPO
6. TomoTherapy to sell medical devices in India
7. TomoTherapy sees sustained market advantage
8. TomoTherapys 100th radiology system reaches public sector
9. TomoTherapy extends reach to Germany
10. Cash-rich TomoTherapy has no plans for IPO
11. City of Hope adds second TomoTherapy system
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/18/2017)... ... January 18, 2017 , ... MYOLYN, which creates medical technology ... a 510(k) to the FDA, requesting clearance of the MyoCycle Home and the ... technology. , The submission marks a major milestone for the technology startup. ...
(Date:1/18/2017)... ... January 18, 2017 , ... ... 2017, to sell research and genetic testing lab equipment from two different leading institutes. ... Northwest and Northeast regions of the United States. This 1-day online auction will ...
(Date:1/18/2017)... Shareholder rights law firm Johnson & Weaver, ... members of CoLucid Pharmaceuticals, Inc. (NASDAQ: CLCD ... proposed sale of the Company to Eli Lilly and ... molecules for the acute treatment of migraines. ... a definitive merger agreement with Eli Lilly. Under the ...
(Date:1/18/2017)... TORONTO , Jan. 18, 2017 /PRNewswire/ - ... life sciences and diagnostics company that develops and ... diagnostics ("SQI" or the "Company"), today announced that ... Markets Inc. ("Kingsdale"), has resigned from its Board ... recent changes to securities regulations that have limited ...
Breaking Biology Technology:
(Date:1/6/2017)... , Jan. 6, 2017  Privately-held CalciMedica, Inc., ... in healthy volunteers of a novel calcium release-activated ... acute pancreatitis. Acute pancreatitis, sudden ... mild disorder, but can be very serious.  In severe ... sepsis, where extended hospital stays, time in the ...
(Date:1/4/2017)... 2017  For the thousands of attendees at this year,s International Consumer ... health and biometric measurement devices and services, will be featuring its new ... in A&D Medical,s special CES Exhibit Suite , the new upper ... the company,s WellnessConnected product platform.  ... ...
(Date:12/22/2016)... MOUNTAIN VIEW, Calif. , Dec. 20, 2016  As ... all levels, 23andMe, the leading personal genetics company, recently released ... Only Me . The book focuses on the topics ... the Next Generation Science Standards (NGSS) taught in elementary school ... the second in a series by illustrator Ariana Killoran ...
Breaking Biology News(10 mins):